BAVA Bavarian Nordic A/S

Bavarian Nordic – Completion of Share Buy-Back Program

Bavarian Nordic – Completion of Share Buy-Back Program

COPENHAGEN, Denmark, February 9, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on January 7, 2026, has now been completed, reaching an aggregate amount of approximately DKK 150 million as planned. This represented the first tranche of a total planned share buy-back of up to DKK 500 million in 2026. Bavarian Nordic will hold the shares bought back as treasury stock, for the purpose of adjusting the capital structure.

The program was executed in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU) 2016/1052, which together constitute the Safe Harbour Regulation.

A total of 764,558 shares were purchased under the program. Since the last announcement of transactions on February 2, 2026, the following transactions have been made by Nordea on behalf of Bavarian Nordic:

 Number of sharesAverage purchase price, DKKTransaction value, DKK
Accumulated until February 2, 2026636,309196.69125,158,539
February 2, 2026 32,215190.43 6,134,622
February 3, 2026 177194.30 34,390
February 4, 2026 25,591194.31 4,972,510
February 5, 2026 63,613195.25 12,420,610
February 6, 2026 6,653192.28 1,279,247
Accumulated under the program764,558196.19149,999,918

The details for each transaction made under the share repurchase program are published on .

Following these transactions, Bavarian Nordic holds a total of 1,731,403 treasury shares, corresponding to 2.19% of the Company’s share capital.

About Bavarian Nordic

Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit

Forward-looking statements

This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly

Contact investors:

Europe: Disa Tuominen, IR Manager,

US: Graham Morrell, Gilmartin Group, , Tel:

Contact media:

Nicole Seroff, Vice President Corporate Communications, , Tel:

Company Announcement no. 06 / 2026

Attachments



EN
09/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE

Paul Chaplin fratræder som administrerende direktør i Bavarian Nordic

Paul Chaplin fratræder som administrerende direktør i Bavarian Nordic KØBENHAVN, Danmark, 2. marts 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag, at bestyrelsen har indgået en aftale med administrerende direktør, Paul Chaplin, som ønsker at træde tilbage af personlige årsager. Paul Chaplin vil fortsætte i sin rolle indtil udgangen af 2026 eller indtil en efterfølger er identificeret. Bestyrelsen har igangsat processen med at identificere en ny administrerende direktør. Paul Chaplin har været hos Bavarian Nordic siden 1999 og blev udnævnt til administrerende direktør i 2014....

 PRESS RELEASE

Paul Chaplin Steps Down as CEO of Bavarian Nordic

Paul Chaplin Steps Down as CEO of Bavarian Nordic COPENHAGEN, Denmark, March 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today, that the Board of Directors has entered into an agreement with CEO, Paul Chaplin, who wishes to step down for personal reasons. Paul Chaplin will continue in his role for the remainder of 2026, or until a successor has been identified. The Board of Directors has initiated the process to identify a new CEO. Paul Chaplin has been with Bavarian Nordic since 1999 and was appointed CEO in 2014. He has led the development of the Company’s smallpox and mpox vacci...

 PRESS RELEASE

Bavarian Nordic offentliggør foreløbige resultater for 2025 og forvent...

Bavarian Nordic offentliggør foreløbige resultater for 2025 og forventninger til 2026 Resultatet overgår de seneste forventninger til 2025 efter en stærk udvikling i begge kommercielle forretningsben, Travel Health og Public Preparedness.Forventningerne til 2026 afspejler en fortsat vækst i Travel Health (10% fra egne produkter, 14% i konstant valuta) og et normaliseret år inden for Public Preparedness, begge områder i overensstemmelse med selskabets offentliggjorte vækstambitioner på mellemlang sigt. KØBENHAVN, Danmark, 12. februar 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i ...

 PRESS RELEASE

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provide...

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026 Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public Preparedness.2026 guidance reflects continued growth in Travel Health (10% from own products, 14% at constant exchange rates) and a normalized year in Public Preparedness, both in line with the communicated mid-term growth ambitions. COPENHAGEN, Denmark, February 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced preliminary, unaudited financial results for 2025 a...

 PRESS RELEASE

Bavarian Nordic – afslutning af aktietilbagekøbsprogram

Bavarian Nordic – afslutning af aktietilbagekøbsprogram KØBENHAVN, Danmark, 9. februar 2026 – Bavarian Nordic A/S (OMX: BAVA) meddeler, at aktietilbagekøbsprogrammet, der blev offentliggjort og iværksat den 7. januar 2026, nu er afsluttet, da aktier til en samlet værdi af ca. DKK 150 mio. er tilbagekøbt som planlagt. Dette udgjorde den første del af et samlet planlagt aktietilbagekøb på op til DKK 500 mio. i løbet af 2026. Bavarian Nordic vil beholde de tilbagekøbte aktier som egne aktier med det formål at tilpasse kapitalstrukturen. Programmet blev gennemført i overensstemmelse med bestem...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch